GeNeuro   Report issue

For profit Phase 2
Founded: Geneva Switzerland (2006)

Organization Overview

First Clinical Trial
2011
NCT01699555
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

GeNeuro Australia PTY Ltd | GeNeuro Innovation SAS | GeNeuro SA